Advances in Traditional Medicine

Kyung Hee Oriental Medicine Research Center (경희대학교 융합한의과학연구소)
권호 표지
DOI QR코드

DOI QR Code

Gene-gene interaction in cerebral infarction patients: Relationship between apolipopreotein E gene polymorphism and Sasang-constitution

  • Um, Jae-Young (Department of Pharmacology, College of Oriental Medicine, Kyung Hee University,College of Pharmacy, Wonkwang University) ;
  • Kim, Jong-Kwan (College of Oriental Medicine, Wonkwang University) ;
  • Joo, Jong-Cheon (College of Oriental Medicine, Wonkwang University) ;
  • Kim, Kyung-Yo (College of Oriental Medicine, Wonkwang University) ;
  • Hong, Seung-Heon (College of Pharmacy, Wonkwang University) ;
  • Kim, Hyung-Min (Department of Pharmacology, College of Oriental Medicine, Kyung Hee University)
  • Published : 2004.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Sasang Constitutional Medicine is a major branch of Korean Traditional Oriental Medicine. The differences of disease susceptibility to be shown in Sasang constitution may be due to genetic factors. Therefore, we examined interrelationship among cerebral infarction (CI), apolipoprotein E (apoE) gene polymorphism, and Sasang constitutional classification. ApoE is a key protein modulating the highly atherogenic apoB containing lipoproteins and is a candidate gene for the development of coronary artery disease (CAD). The ${\varepsilon}2\;and/or\;{\varepsilon}4$ alleles were the first to be implicated in premature CAD, which resulted in this polymorphism being extensively studied. We investigated the association between apoE genotype and CI by case-control study in a Korean population. We also classified CI patients and control group into groups according to Sasang Constitutional Medicine. 196 CI patients and 379 controls without CI were examined. ApoE genotype was determined by 8% polyacrylamide gel separation after DNA amplification. A significant difference in the apoE genotype distribution was observed in the CI patients compared with that in controls ($X^{2}$=14.920, df=4, P=0.005). Also, the frequency of Taeumin constitution in patients with CI was significantly higher than that in controls (58.0% vs. 36.9%; P<0.001). However, the Taeumin constitution did not enhance the relative risk for CI in the subjects with apoE ${\varepsilon}2\;and/or\;{\varepsilon}4$ alleles. No differences in the apoE genotypes frequencies were observed in the Taeumin compared with that in the other constitutions. In addition, we investigated whether the DD genotype of angiotensin converting enzyme (ACE) gene, a candidate gene for CI, was associated with CI, Taeumin constitution, and apoE polymorphism. As a result, the frequency of Taeumin constitution was significantly higher in CI patients with both apoE ${\varepsilon}3/{\varepsilon}4$ and ACE ID/DD genotypes than in the remaining Sasang constitutions (14.5% vs. 8.3% and 0%) ($X^{2}$=13.521, df=6, P=0.035). In summary, we concluded that the apoE polymorphism is a major risk factor for CI in Koreans and the ACE ID/DD genotype enhanced the relative risk for CI in the subjects with apoE ${\varepsilon}3/{\varepsilon}4$ genotype and Taeumin constitution.

Keywords

References

  1. Abbud ZA, Wilson AC, Cosgrove NM, Kostis JB. (1998) Angiotensin-converting enzyme gene polymorphism in systemic hypertension. Am. J. Cardiol. 81, 244-246. https://doi.org/10.1016/S0002-9149(97)00876-X
  2. Brega A, Scacchi R, Cuccia M, Kirdar B, Peloso G, Corbo RM. (1998) Study of 15 protein polymorphisms in a sample of the Turkish population. Hum. Biol. 70, 715-728.
  3. Catto AJ, McCormack LJ, Mansfield MW, Carter AM, Bamford JM, Robinson P, Grant PJ. (2001) Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol. Scand. 101, 399-404.
  4. Couderc R, Mahieux F, Bailleul S. (1994) Apolipoprotein E allele frequency in ischemic cerebrovascular disease and Alzheimers disease. Stroke 24, 1416-1417.
  5. Davignon J, Gregg RE, Sing CF. (1988) Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 8, 1-21.
  6. Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, White R, Lalouel JM. (1988) Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3, 373-379. https://doi.org/10.1016/0888-7543(88)90130-9
  7. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, Crane J, ORourke DF, Cambien F. (1994) Polymorphisms of the angiotensin-converting enzyme gene in subjects who die from coronary heart disease. Q. J. Med. 87,211-214.
  8. Falconer DS. (1981) Introduction to Quantitative Genetics, Longman, London.
  9. Fisher RA. (1918) The correlation between relatives under the supposition of mendelian inheritance. Trans. Roy. Soc. 52, 399-433.
  10. Frikke-Schmidt R, Nordestgaard BG, Thudium D, Moes Gronholdt ML, Tybjaerg-Hansen A. (2001) APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease. Neurology 56, 194-200. https://doi.org/10.1212/WNL.56.2.194
  11. Hixon JE. (1991) Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Apolipoprotein E polymorphism affects atherosclerosis in young males. Arterioscler. Thromb. 11, 1237-1244. https://doi.org/10.1161/01.ATV.11.5.1237
  12. Kario K, Kanai N, Saito K, Nago N, Matsuo T, Shimada K. (1996) Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 93, 1630-1633. https://doi.org/10.1161/01.CIR.93.9.1630
  13. Kokubo Y, Chowdhury AH, Date C, Yokoyama T, Sobue H, Tanaka H. (2000) Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 31, 1299-1306. https://doi.org/10.1161/01.STR.31.6.1299
  14. Kosunen O, Talasniemi S, Lehtovirta M, Heinonen O, Helisalmi S, Mannermaa A, Paljarvi L, Ryynanen M, Riekkinen PSr., Soininen H. (1995) Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 26, 743-748. https://doi.org/10.1161/01.STR.26.5.743
  15. Kowalska A, Wiechmann I, Waiter H. (1998) Genetic variability of apolipoprotein E in a Polish population. Hum. Biol. 70, 1093-1099.
  16. Kumar T, Liestol K, Maehlen J, Hiorth A, Jettestuen E, Lind H, Brorson SH. (2002) Allele frequencies of apolipoprotein E gene polymorphisms in the protein coding region and promoter region (-491A/T) in a healthy Norwegian population. Hum. Biol. 74, 137-142. https://doi.org/10.1353/hub.2002.0006
  17. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, laakso M. (1995) Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler. Thromb. Vasc. Biol. 15, 1280-1286. https://doi.org/10.1161/01.ATV.15.9.1280
  18. Ledru F, Blanchard D, Battaglia S, Jeunemaitre X, Courbon D, Guize L, Guermonprez JL, Oucimetiere P, Diebold B. (1998) Relation between severity of coronary artery disease, left ventricular function and myocardial infarction, and influence of the ACE I/D gene polymorphism. Am. J. Cardiol. 82, 160-165. https://doi.org/10.1016/S0002-9149(98)00304-X
  19. Lee JM. (1996) Longevity & Life Preservation In Oriental Medicine, edited by Choi SH, Kyung Hee University Press, Korea.
  20. MacLeod MJ, De Lange RP, Breen G, Meiklejohn D, Lemmon H, Clair DS. (2001) Lack of association between apolipoprotein E genotype and ischaemic stroke in a Scottish population. Eur. J. Clin. Invest. 31, 570-573. https://doi.org/10.1046/j.1365-2362.2001.00851.x
  21. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, Brown MM. (1995) Angiotensin-converting enzyme gene deletion polymorphism-A new risk factor for lacunar stroke but not carotid atheroma. Stroke 26, 1329-1333. https://doi.org/10.1161/01.STR.26.8.1329
  22. McCarron MO, Delong D, Alberts MJ. (1999) APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 53, 1308-1311. https://doi.org/10.1212/WNL.53.6.1308
  23. Miller SA, Dykes DD, Polesky HF. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215. https://doi.org/10.1093/nar/16.3.1215
  24. Nakata Y, Katsuya T, Rakugi H, Takami S, Sato N, Kamide K, Ohishi M, Miki T, Higaki J, Ogihara T. (1997) Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am. J. Hypertens. 10, 1391-1395. https://doi.org/10.1016/S0895-7061(97)00315-4
  25. Odawara M, Sasaki K, Yamashita K. (1996) Beta 3-adrenergic receptor gene variant and Japanese NIDOM: a pitfall in meta-analysis. Lancet 348, 896-897.
  26. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olive J. (1992) Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 23, 1556-1562. https://doi.org/10.1161/01.STR.23.11.1556
  27. Rigat B, Hubert C, Alhenc-Gelas P, Cambien F, Corvol P, Soubrier F. (1990) An insertion/ deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343-1346. https://doi.org/10.1172/JCI114844
  28. Seino Y, Ikeda U, Maeda Y, Haga Y, Yashima H, Shimada K. (1998) Angiotensin-converting enzyme gene polymorphism and plasminogen activator inhibitor 1 levels in subjects with cerebral infarction. J. Thromb. Thrombolysis 5, 263-267. https://doi.org/10.1023/A:1008804211738
  29. Sharma P, Carter NO, Barley J, Brown MM. (1994) Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin I-converting enzyme. J. Hum. Hypertens. 8, 645-648.
  30. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM, Visvikis S. (1995) Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin. Chem. 41, 1068-1086.
  31. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme(ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 51, 197-205.
  32. Ueda S, Weir CJ, Inglis GC, Murray GD, Muir KW, Lees KR. (1995) Lack of association between angiotensin converting enzyme and gene insertion/ deletion polymorphism and stroke. J. Hypertens. 13, 1597-1601.
  33. Vleming LJ, van der Pijl JW, Lemkes HH, Westendorp RG, Maassen JA, Daha MR, van Es LA, van Kooten C. (1999) The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure IIDDM. Clin. Nephrol. 51, 133-140.
  34. Wang XL, McCredie RM, Wilcken DE. (1995) Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler. Thromb. Vasc. Biol. 15, 1030-1034. https://doi.org/10.1161/01.ATV.15.8.1030
  35. Wiemer G, Scholkens BA, Becker RH, Busse R. (1991) Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 18, 558-563. https://doi.org/10.1161/01.HYP.18.4.558
  36. Wu JH, Lo SK, Wen MS, Kao JT. (2002) Characterization of apolipoprotein E genetic variations in Taiwanese: association with coronary heart disease and plasma lipid levels. Hum. Biol. 74, 25-31. https://doi.org/10.1353/hub.2002.0012
  37. Zaman MM, Ikemoto S, Yoshiike N, Date C, Yokoyama T, Tanaka H. (1997) Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population. The Shibata Study. Arterioscler. Thromb. Vasc. Biol. 17, 3495-3504. https://doi.org/10.1161/01.ATV.17.12.3495